Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Baggerly

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Molecular Cancer Therapeutics|April 2, 2013
Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIPXuemei Xie, Chandra Bartholomeusz, Ahmed A Ahmed, et al.
European Journal of Human Genetics : EJHG|March 3, 2011
Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in FinlandTiina Suominen, Linda L Bachinski, Satu Auvinen, et al.
Bioinformatics (Oxford, England)|November 24, 2006
PrepMS: TOF MS data graphical preprocessing toolYuliya V Karpievitch, Elizabeth G Hill, Adam J Smolka, et al.
Head & Neck|July 22, 2008
Molecular signatures of metastasis in head and neck cancerStefano Colella, Kristy L Richards, Linda L Bachinski, et al.
Molecular Cancer Research : MCR|October 12, 2014
Clinically relevant microRNAs in ovarian cancerShu Zhang, Zhen Lu, Anna K Unruh, et al.
Breast Cancer Research and Treatment|July 16, 2009
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell linesCornelia Liedtke, Jing Wang, Attila Tordai, et al.
The Oncologist|August 14, 2014
Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancerNaoki Hayashi, Ganiraju C Manyam, Ana M Gonzalez-Angulo, et al.
Ebiomedicine|May 7, 2019
Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cellsMichael H McGuire, Shelley M Herbrich, Santosh K Dasari, et al.
Acta Haematologica|May 22, 2019
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell TransplantationZhihong Zeng, Wenbin Liu, Christopher B Benton, et al.
BMC Genomics|May 14, 2008
Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arraysHannah C Cheung, Keith A Baggerly, Spiridon Tsavachidis, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Molecular Cancer Therapeutics|April 2, 2013
Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIPXuemei Xie, Chandra Bartholomeusz, Ahmed A Ahmed, et al.
European Journal of Human Genetics : EJHG|March 3, 2011
Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in FinlandTiina Suominen, Linda L Bachinski, Satu Auvinen, et al.
Bioinformatics (Oxford, England)|November 24, 2006
PrepMS: TOF MS data graphical preprocessing toolYuliya V Karpievitch, Elizabeth G Hill, Adam J Smolka, et al.
Head & Neck|July 22, 2008
Molecular signatures of metastasis in head and neck cancerStefano Colella, Kristy L Richards, Linda L Bachinski, et al.
Molecular Cancer Research : MCR|October 12, 2014
Clinically relevant microRNAs in ovarian cancerShu Zhang, Zhen Lu, Anna K Unruh, et al.
Breast Cancer Research and Treatment|July 16, 2009
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell linesCornelia Liedtke, Jing Wang, Attila Tordai, et al.
The Oncologist|August 14, 2014
Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancerNaoki Hayashi, Ganiraju C Manyam, Ana M Gonzalez-Angulo, et al.
Ebiomedicine|May 7, 2019
Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cellsMichael H McGuire, Shelley M Herbrich, Santosh K Dasari, et al.
Acta Haematologica|May 22, 2019
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell TransplantationZhihong Zeng, Wenbin Liu, Christopher B Benton, et al.
BMC Genomics|May 14, 2008
Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arraysHannah C Cheung, Keith A Baggerly, Spiridon Tsavachidis, et al.
Pageof 10